OptiBiotix Health (GB:OPTI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OptiBiotix Health’s recent study at Roehampton University shows that their product SlimBiome significantly reduces hunger and food cravings, promoting feelings of fullness, which may offer a natural and effective alternative to anti-obesity drugs. The study’s participants also experienced reductions in body fat and an improvement in mood, indicating a sustainable approach to weight management without the adverse effects commonly associated with anti-obesity medications. SlimBiome’s use in various food products could potentially tap into the burgeoning market for healthy weight management solutions.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.